SCHEMBL4423221

SCHEMBL4423221

CSc1nc(-c2cccc(N)c2)c2c(N)c(C(=O)O)ccc2n1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LHCGR P22888 6/20 0.41
MCL1 Q07820 1/20 0.40
KDM4E B2RXH2 2/20 0.40
TSHR P16473 1/20 0.40
CSNK2A2 P19784 1/20 0.38
CSNK2B P67870 1/20 0.38
SMN1; SMN2 Q16637 2/20 0.35
MEN1 O00255 1/20 0.35
KMT2A Q03164 1/20 0.35
BRAF P15056 1/20 0.35
PDE4A P27815 1/20 0.35
PDE4B Q07343 1/20 0.35
PDE4C Q08493 1/20 0.35
PDE4D Q08499 1/20 0.35
NPC1 O15118 2/20 0.34
RAB9A P51151 2/20 0.34
PIK3CG P48736 1/20 0.34
ALDH1A1 P00352 1/20 0.34
MAPT P10636 1/20 0.34
HPGD P15428 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4432379 0.91 LHCGR (0.43) LHCGRMCL1KDM4ETSHRCSNK2A2
SCHEMBL4423898 0.87 LHCGR (0.55) LHCGRKDM4ETSHRCSNK2A2CSNK2B
SCHEMBL4422167 0.85 LHCGR (0.55) LHCGRKDM4ETSHRMEN1KMT2A
SCHEMBL4421572 0.85 SMN1; SMN2 (0.50) LHCGRKDM4ETSHRSMN1; SMN2NPC1
SCHEMBL4423903 0.81 LHCGR (0.54) LHCGRKDM4ETSHRCSNK2A2SMN1; SMN2
SCHEMBL7143226 0.80 LHCGR (0.51) LHCGRKDM4ETSHRKMT2AALDH1A1
SCHEMBL4418728 0.78 LHCGR (0.57) LHCGRKDM4ETSHRBRAFPDE4A
SCHEMBL5025967 0.76 LHCGR (0.62) LHCGRKDM4ETSHRMEN1KMT2A
SCHEMBL4430421 0.76 LHCGR (0.66) LHCGRKDM4ETSHRCSNK2A2BRAF
SCHEMBL4422170 0.75 LHCGR (0.42) LHCGRKDM4ETSHRSMN1; SMN2BRAF

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7618963-B2 Bicyclic heteroaromatic compounds N.V. ORGANON (NL) 2009-11-17 US disclosed
EP-1886999-A2 Bicyclic heteroaromatic compound N.V. Organon (NL) 2008-02-13 EP disclosed
US-20070197527-A1 Bicyclic heteroaromatic compounds N.V. ORGANON (NL) 2007-08-23 US disclosed
US-7229990-B2 Bicyclic heteroaromatic compounds N.V. ORGANON (NL) 2007-06-12 US disclosed
CN-1247594-C Bicyclic heteroaromatic compounds OKZO NOBEL N V (NL) 2006-03-29 CN disclosed
CN-1462273-A Bicyclic heteroaromatic compounds OKZO NOBEL N V (NL) 2003-12-17 CN disclosed
US-20030225113-A1 Bicyclic heteroaromatic compounds MERCK SHARP & DOHME B.V. (NL) 2003-12-04 US disclosed
EP-1322651-A1 BICYCLIC HETEROAROMATIC COMPOUNDS Akzo Nobel N.V. (NL) 2003-07-02 EP disclosed
WO-2002024703-A1 BICYCLIC HETEROAROMATIC COMPOUNDS AKZO NOBEL N.V. (NL) 2002-03-28 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030225113-A1 Bicyclic heteroaromatic compounds NR5A1, CYP19A1, FSHR LHCGR 13/4885MCL1 2732/4885KDM4E 1309/4885
US-20070197527-A1 Bicyclic heteroaromatic compounds NR5A1, CYP19A1, FSHR LHCGR 10/4885MCL1 2660/4885KDM4E 1074/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.